Zobrazeno 1 - 10
of 57
pro vyhledávání: ''
Autor:
Loreto Carmona, Lene Terslev, Michael Doherty, Jenny de la Torre-Aboki, Ingrid Möller Parera, Elena Nikiphorou, Will Uwe Kampen, Raul Castellanos-Moreira, Esperanza Naredo, Maria Antonietta D'Agostino, Francis Berenbaum, Jacqueline Uson, Terence W O'Neill, Sebastian C. Rodriguez-García, Irene A Pitsillidou, Mikael Boesen, Hemant Pandit, V. Vardanyan
Publikováno v:
RMD Open : Rheumatic & Musculoskeletal Diseases
RMD Open : Rheumatic & Musculoskeletal Diseases, BMJ, 2021, 7 (2), pp.e001658. ⟨10.1136/rmdopen-2021-001658⟩
RMD Open
RMD Open : Rheumatic & Musculoskeletal Diseases, EULAR ; BMJ, 2021, 7 (2), pp.e001658. ⟨10.1136/rmdopen-2021-001658⟩
Rodriguez-García, S C, Castellanos-Moreira, R, Uson, J, Naredo, E, O'Neill, T W, Doherty, M, Boesen, M, Pandit, H, Möller Parera, I, Vardanyan, V, Terslev, L, Kampen, W U, D'Agostino, M A, Berenbaum, F, Nikiphorou, E, Pitsillidou, I, De La Torre-Aboki, J & Carmona, L 2021, ' Efficacy and safety of intra-articular therapies in rheumatic and musculoskeletal diseases : An overview of systematic reviews ', RMD Open, vol. 7, no. 2, 001658, pp. 1-20 . https://doi.org/10.1136/rmdopen-2021-001658
RMD Open, Vol 7, Iss 2 (2021)
r-ISABIAL. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica y Sanitaria de Alicante
instname
RMD Open : Rheumatic & Musculoskeletal Diseases, BMJ, 2021, 7 (2), pp.e001658. ⟨10.1136/rmdopen-2021-001658⟩
RMD Open
RMD Open : Rheumatic & Musculoskeletal Diseases, EULAR ; BMJ, 2021, 7 (2), pp.e001658. ⟨10.1136/rmdopen-2021-001658⟩
Rodriguez-García, S C, Castellanos-Moreira, R, Uson, J, Naredo, E, O'Neill, T W, Doherty, M, Boesen, M, Pandit, H, Möller Parera, I, Vardanyan, V, Terslev, L, Kampen, W U, D'Agostino, M A, Berenbaum, F, Nikiphorou, E, Pitsillidou, I, De La Torre-Aboki, J & Carmona, L 2021, ' Efficacy and safety of intra-articular therapies in rheumatic and musculoskeletal diseases : An overview of systematic reviews ', RMD Open, vol. 7, no. 2, 001658, pp. 1-20 . https://doi.org/10.1136/rmdopen-2021-001658
RMD Open, Vol 7, Iss 2 (2021)
r-ISABIAL. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica y Sanitaria de Alicante
instname
ObjectiveTo summarise the evidence on intra-articular therapies (IAT) to inform the 2020 EULAR recommendations.MethodsAn overview of systematic reviews (SR) including randomised-controlled trials (RCTs) of IAT in adults with arthropathies was perform
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::612e9a0f282aa61fa30b0502b4ae95cb
https://hal.sorbonne-universite.fr/hal-03354092
https://hal.sorbonne-universite.fr/hal-03354092
Publikováno v:
Rheumatology International
Rheumatology International, Springer Verlag, In press, ⟨10.1007/s00296-020-04692-4⟩
Rheumatology International, Springer Verlag, In press, ⟨10.1007/s00296-020-04692-4⟩
International audience; To develop and validate a self-administered questionnaire to identify in people with Inflammatory arthritis (IA) Facilitators And Barriers to Physical activity (PA): the IFAB questionnaire. The development of the questionnaire
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::eb5c6df775f713be5a313ee9b7494831
https://hal.sorbonne-universite.fr/hal-02948880/document
https://hal.sorbonne-universite.fr/hal-02948880/document
Autor:
Mark T. Brown, Rod Junor, Kenji Miki, Francisco J. Blanco, Christine R. West, Francis Berenbaum, Takaharu Yamabe, Kenneth M. Verburg, Ali Guermazi, William Carey, Lars Viktrup
Publikováno v:
Annals of the Rheumatic Diseases
Annals of the Rheumatic Diseases, BMJ Publishing Group, 2020, 79 (6), pp.800-810. ⟨10.1136/annrheumdis-2019-216296⟩
RUC. Repositorio da Universidade da Coruña
instname
RUC: Repositorio da Universidade da Coruña
Universidade da Coruña (UDC)
Annals of the Rheumatic Diseases, BMJ Publishing Group, 2020, 79 (6), pp.800-810. ⟨10.1136/annrheumdis-2019-216296⟩
RUC. Repositorio da Universidade da Coruña
instname
RUC: Repositorio da Universidade da Coruña
Universidade da Coruña (UDC)
ObjectiveTanezumab, a nerve growth factor inhibitor, was investigated for osteoarthritis (OA) of the hip or knee in a study with 24-week treatment and 24-week safety follow-up.MethodsThis double-blind, randomised, phase III study enrolled adults in E
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::478e5b2ef02f6e8fb2fad6b39ef1ad89
https://hal.sorbonne-universite.fr/hal-02932100/file/800.full.pdf
https://hal.sorbonne-universite.fr/hal-02932100/file/800.full.pdf
Autor:
Alejandro Balsa, Sarah Witt, Maxime Dougados, Frederick Durand, Bernard Combe, Veronica Rogai, Hans-Peter Tony, Piercarlo Sarzi-Puttini, Jinglin Zhong, Inmaculada de la Torre
Publikováno v:
Annals of the Rheumatic Diseases
Annals of the Rheumatic Diseases, BMJ Publishing Group, 2019, 78 (8), pp.1135-1138. ⟨10.1136/annrheumdis-2018-214261⟩
Annals of the Rheumatic Diseases, BMJ Publishing Group, 2019, 78 (8), pp.1135-1138. ⟨10.1136/annrheumdis-2018-214261⟩
Patients with rheumatoid arthritis (RA) have a high prevalence of comorbidities.1 This post-hoc analysis investigated the effect of select comorbidities (depression, osteoporosis, hepatic, cardiovascular or pulmonary disorders) on the efficacy and sa
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9318f1ca9785da707f4e960bf1241187
https://hal.umontpellier.fr/hal-02882173
https://hal.umontpellier.fr/hal-02882173
Autor:
Elisabeth Spitz, Hakima Manseur, Michel Cembalo, Hema Urban, Annica Barcenilla-Wong, Camille Alleyrat, Camille Ricatte, Philip G. Conaghan, Gillian A. Hawker, Lyn March, Bruno Fautrel, Claudia Rutherford, Thomas Buttel, Amandine Schoumacker, David J. Hunter, Marita Cross, Francis Guillemin
Publikováno v:
Journal of Rheumatology
Journal of Rheumatology, Journal of Rheumatology Publishing Company Limited, 2019, 46 (9), pp.1188-1191. ⟨10.3899/jrheum.181085⟩
Journal of Rheumatology, Journal of Rheumatology Publishing Company Limited, 2019, 46 (9), pp.1188-1191. ⟨10.3899/jrheum.181085⟩
Flare in knee and hip osteoarthritis (OA) is more than just an exacerbation of pain. Unstructured, semistructured, and focus group interviews followed by Delphi surveys with patients and health professionals (HP) generated candidate domains of an OA
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::dcd2c859de13ee853a8b1a7bb180334d
https://hal.univ-lorraine.fr/hal-02142347
https://hal.univ-lorraine.fr/hal-02142347
Publikováno v:
Annals of the Rheumatic Diseases
Annals of the Rheumatic Diseases, 2018, 77 (5), pp.782--783. ⟨10.1136/annrheumdis-2017-211447⟩
Annals of the rheumatic diseases, 77(5), 782-783. BMJ Publishing Group
Annals of the Rheumatic Diseases, 77(5), 782
Annals of the Rheumatic Diseases, 2018, 77 (5), pp.782--783. ⟨10.1136/annrheumdis-2017-211447⟩
Annals of the rheumatic diseases, 77(5), 782-783. BMJ Publishing Group
Annals of the Rheumatic Diseases, 77(5), 782
While enthesitis, dactylitis and nail involvement are recognised as important outcomes of psoriatic arthritis (PsA) in the core set of domains in PsA,1 2 it is still unclear how these outcomes should best be measured.1 2 We systematically reviewed th
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d02cea4737c92986e523e344db461bb3
https://hal.sorbonne-universite.fr/hal-03879097
https://hal.sorbonne-universite.fr/hal-03879097
Autor:
Pierre Chauvin, V. Saulot, Thibault de Chalus, Jean-Michel Joubert, Alain Saraux, Christophe Hudry, Francis Berenbaum, Laure Gossec, Caroline Dreuillet, F. Russo-Marie, Sabine Tong, G. Cukierman
Publikováno v:
Annals of the Rheumatic Diseases
Annals of the Rheumatic Diseases, BMJ Publishing Group, 2018, 77 (2), pp.258-263. ⟨10.1136/annrheumdis-2017-212000⟩
Annals of the Rheumatic Diseases, BMJ Publishing Group, 2018, 77 (2), pp.258-263. ⟨10.1136/annrheumdis-2017-212000⟩
ObjectivesTo develop and validate an outcome measure for assessing fears in patients with rheumatoid arthritis (RA) and axial spondyloarthritis (axSpA).MethodsFears were identified in a qualitative study, and reformulated as assertions with which par
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7a466b48be4968f294b6374a41ad6113
https://hal.archives-ouvertes.fr/hal-01795691
https://hal.archives-ouvertes.fr/hal-01795691
Autor:
Cédric Lukas, Cécile Gaujoux-Viala, C. Hua, Bernard Combe, Thomas Barnetche, Claire Rempenault, Jacques Morel
Publikováno v:
Annals of the Rheumatic Diseases
Annals of the Rheumatic Diseases, BMJ Publishing Group, 2018, 77 (1), pp.98--103. ⟨10.1136/annrheumdis-2017-211836⟩
Annals of the Rheumatic Diseases, BMJ Publishing Group, 2018, 77 (1), pp.98--103. ⟨10.1136/annrheumdis-2017-211836⟩
ObjectiveCardiovascular disease (CVD) is the leading cause of mortality in patients with rheumatoid arthritis (RA). Hydroxychloroquine (HCQ) has been shown to improve survival rates in other inflammatory diseases. We aimed to assess the available lit
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c81c4080b1f496292123efb7e6c3832e
https://hal.archives-ouvertes.fr/hal-02350944
https://hal.archives-ouvertes.fr/hal-02350944
Autor:
A. Tubery, Guilhem du Cailar, Jacques Morel, Claire Daien, Bernard Combe, Jean Bousquet, Pierre Fesler, François Roubille, Thibault Mura
Publikováno v:
Annals of the Rheumatic Diseases
Annals of the Rheumatic Diseases, 2018, 77 (4), pp.625--626. ⟨10.1136/annrheumdis-2017-211074⟩
Annals of the Rheumatic Diseases, 2018, 77 (4), pp.625--626. 〈10.1136/annrheumdis-2017-211074〉
Annals of the Rheumatic Diseases, BMJ Publishing Group, 2018, 77 (4), pp.625--626. ⟨10.1136/annrheumdis-2017-211074⟩
Annals of the Rheumatic Diseases, 2018, 77 (4), pp.625--626. ⟨10.1136/annrheumdis-2017-211074⟩
Annals of the Rheumatic Diseases, 2018, 77 (4), pp.625--626. 〈10.1136/annrheumdis-2017-211074〉
Annals of the Rheumatic Diseases, BMJ Publishing Group, 2018, 77 (4), pp.625--626. ⟨10.1136/annrheumdis-2017-211074⟩
The European League Against Rheumatism (EULAR) recently updated the recommendations for cardiovascular disease (CVD) risk management in patients with rheumatoid arthritis (RA).1 In contrast to the 2009 recommendations which advised to multiply by 1.5
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7f6cc60719ef4b833d4463638de39385
https://hal.science/hal-01761697
https://hal.science/hal-01761697
Autor:
Marita Cross, Francis Guillemin, Gillian A. Hawker, Ludovic Dubouis, Matthieu Mangin, David J. Hunter, Lyn March
Publikováno v:
Journal of Rheumatology
Journal of Rheumatology, Journal of Rheumatology Publishing Company Limited, 2017, 44 (12), pp.1920-1927. ⟨10.3899/jrheum.161107⟩
Journal of Rheumatology, Journal of Rheumatology Publishing Company Limited, 2017, 44 (12), pp.1920-1927. ⟨10.3899/jrheum.161107⟩
Objective.Beyond the exacerbation of pain in describing a flare in osteoarthritis (OA), patients and health professionals add other elements that deserve to be fully elucidated, such as effusion, swelling, and mobility limitation. To define and conce
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5486e093800be4ca7a24a263e47545d4
https://hal.univ-lorraine.fr/hal-02337537
https://hal.univ-lorraine.fr/hal-02337537